Malvern, Pennsylvania
United States
17
2021-03-11
11
2022-03-08
These are the the leading inventors for applications assigned to PhaseBio Pharmaceuticals, Inc.:
PhaseBio Pharmaceuticals, Inc. based in Malvern, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods and compositions for treating muscle disease and disorders
#2 | 2020-12-17 ✅ Patent 11,136,309 granted on 2021-10-05Metalloenzyme inhibitor compounds
#3 | 2019-01-17 ✅ Patent 10,722,590 granted on 2020-07-28ELP fusion proteins for controlled and sustained release
#4 | 2019-01-10 ✅ Patent 11,040,034 granted on 2021-06-22Metalloenzyme inhibitor compounds
#5 | 2018-11-22 ✅ Patent 10,688,156 granted on 2020-06-23Methods and compositions for treating muscle disease and disorders
#6 | 2017-06-29 ✅ Patent 11,052,132 granted on 2021-07-06Methods and compositions for treating cystic fibrosis
#7 | 2017-05-18 ✅ Patent 9,919,032 granted on 2018-03-20Method for administering a sustained release formulation
#8 | 2017-03-16 ✅ Patent 10,940,182 granted on 2021-03-09Use of modified vasoactive intestinal peptides in the treatment of hypertension
#9 | 2016-08-04 ✅ Patent 9,700,598 granted on 2017-07-11Modified vasoactive intestinal peptides
#10 | 2015-04-23 ✅ Patent 9,561,262 granted on 2017-02-07Use of modified vasoactive intestinal peptides in the treatment of hypertension
#11 | 2015-04-23METHODS AND TREATMENT WITH GLP-1 RECEPTOR AGONISTS
#12 | 2014-06-19FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
#13 | 2013-07-11FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
#14 | 2013-06-13THERAPEUTIC AGENTS COMPRISING INSULIN AMINO ACID SEQUENCES
#15 | 2013-06-06FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
#16 | 2013-04-04FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
#17 | 2011-07-21 ✅ Patent 9,029,505 granted on 2015-05-12Modified vasoactive intestinal peptides
Also check out PHASEBIO PHARMACEUTICALS, INC.'s (Malvern, United States) applicant profile with 9 patent applications submitted.
16762 ⎘